Literature DB >> 25555281

The prognostic impact of diastolic dysfunction in patients with chronic heart failure and post-acute myocardial infarction: Can age-stratified E/A ratio alone predict survival?

Marzia Rigolli1, Andrea Rossi2, Miguel Quintana3, Allan L Klein4, Cheuk-Man Yu5, Stefano Ghio6, Frank L Dini7, David Prior8, Richard W Troughton9, Pier L Temporelli10, Katrina K Poppe11, Robert N Doughty11, Gillian A Whalley12.   

Abstract

OBJECTIVE: To determine the prognostic implications of diastolic filling grades and identify whether age-stratified E/A ratio alone can identify patients at high risk of death post-AMI and HF. We hypothesized that in response to ageing and pathology, a normal E/A (>1) could be considered abnormal in patients post-AMI older than 65years, and that in patients with symptomatic HF, a normal E/A always represents advanced diastolic dysfunction. METHODS AND
RESULTS: This is a sub-analysis of the Meta-analysis Research Group in Echocardiography (MeRGE) which combined individual patient data from 30 prospective studies and demonstrated that restrictive filling was an important and independent predictor of all-cause mortality. This sub-analysis is restricted to those studies in which continuous E/A data were available (20 studies) and includes a total of 3082 AMI and 2321 HF patients. Patients were classified at the time of echocardiography into four filling patterns: normal, abnormal relaxation, pseudonormal, and restrictive filling. Post-AMI patients were divided into four groups on the basis of age and E/A, while patients with HF were classified into three groups, based on only E/A. Mortality across groups was compared using Kaplan-Meier survival analysis and Cox proportional hazards. In multivariable analyses in the AMI patients, age-stratified E/A was an independent predictor of outcome (HR 1.43 (95% CI: 1.31-1.56)), and in the HF cohort, E/A was confirmed as an independent predictor of mortality (HR 1.12 (95% CI 1.09-1.16)) alongside age and ejection fraction.
CONCLUSIONS: Age-stratified E/A is an independent predictor of mortality after AMI and in HF patients, regardless of left ventricular ejection fraction, age and gender. E/A ratio could be a first step echocardiographic risk stratification, which could precede and indicate the need for more advanced diagnostic and prognostic considerations in high-risk AMI and HF patients.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diastole; Echocardiography; Heart failure; Meta-analysis; Mortality; Myocardial infarction

Mesh:

Year:  2014        PMID: 25555281     DOI: 10.1016/j.ijcard.2014.12.051

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

Review 1.  Hemodynamic characteristics and early warnings in very old patients.

Authors:  Hui Lian; Xin Ding; Hongmin Zhang; Dawei Liu; Xiaoting Wang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 2.  Assessment and impact of diastolic function by echocardiography in elderly patients.

Authors:  Clementina Dugo; Marzia Rigolli; Andrea Rossi; Gillian A Whalley
Journal:  J Geriatr Cardiol       Date:  2016-03       Impact factor: 3.327

3.  Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry.

Authors:  Agnieszka Kapłon-Cieślicka; Cécile Laroche; Maria G Crespo-Leiro; Andrew J S Coats; Stefan D Anker; Gerasimos Filippatos; Aldo P Maggioni; Camilla Hage; Antonio Lara-Padrón; Alessandro Fucili; Jarosław Drożdż; Petar Seferovic; Giuseppe M C Rosano; Alexandre Mebazaa; Theresa McDonagh; Mitja Lainscak; Frank Ruschitzka; Lars H Lund
Journal:  ESC Heart Fail       Date:  2020-07-02

4.  Surgical Ventricular Restoration for Ischemic Heart Failure: A Glance at a Real-World Population.

Authors:  Serenella Castelvecchio; Valentina Milani; Federico Ambrogi; Marianna Volpe; Lucia Ramputi; Giovanni Soletti; Lorenzo Menicanti
Journal:  J Pers Med       Date:  2022-04-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.